Cite
HARVARD Citation
Curatolo, P. et al. (2018). Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial. Lancet. pp. 495-504. [Online].